Filings and Disclosure

Curative Biotechnology, Inc.

February 12, 2024

Period end date: February 27, 2025 - Status A

Financial Reports and Disclosures

February 12, 2024

Period end date: February 27, 2026 - Status A

SEC filings

November 11, 2021

Period end date: November 11, 2021 - Status I

Quarterly Report - 3rd Quarter Disclosure and Financial Statement

August 23, 2021

Period end date: August 23, 2021 - Status I

Quarterly Report - June 30, 2021 Amended

July 22, 2021

Period end date: July 22, 2021 - Status I

Supplemental Information - Current Reporting of Material Corporate Events

July 15, 2021

Period end date: July 15, 2021 - Status I

Supplemental Information - Current Reporting of Material Corporate Events

June 24, 2021

Period end date: June 24, 2021 - Status I

Supplemental Information - Current Reporting of Material Corporate Events

May 25, 2021

Period end date: March 31, 2021 - Status I

Quarterly Report - March 31, 2021

May 17, 2021

Period end date: March 31, 2021 - Status I

Notification of Late Filing - Notification of Late Filing

April 27, 2021

Period end date: April 27, 2021 - Status I

Current information disclosure

March 30, 2021

Period end date: March 30, 2021 - Status I

Current information disclosure

March 23, 2021

Period end date: March 23, 2021 - Status I

Current information disclosure

March 11, 2021

Period end date: March 11, 2021 - Status I

Disclosure Statement Pursuant to the Pink Basic Disclosure Guidelines

March 11, 2021

Period end date: March 11, 2021 - Status I

Opinion of Counsel regarding Adequate Current Information

November 16, 2020

Period end date: September 30, 2020 - Status I

Quarterly Report - 3rd Quarter Disclosure and Financial Statements

August 13, 2020

Period end date: June 30, 2020 - Status I

Quarterly Report - June 30, 2020

May 14, 2020

Period end date: March 31, 2020 - Status I

Quarterly Report - March 31, 2020